Under construction – not a live service
Sign in
Taking people in FranceNo phase

Diet Study for Women with Overweight or Obesity After Pre-eclampsia

Compares two diets for weight loss in adults with obesity after pre-eclampsia.

Plain-language title generated from the registry record
Registry title: Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients

Key facts

Where
Le Mans, FranceSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

Source: NCT06067906, who can take part

Where in France

  • Centre Hospitalier du MansLe Mans, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centre Hospitalier le Mans
Trial code
NCT06067906
Record updated
28 August 2024
Original description
In view of the known link between pre-eclampsia, overweight/obesity and chronic kidney disease, the aim is to offer for obese and overweight patients to reduce their BMI without reducing lean body mass.Read full original descriptionShow less

Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients

In view of the known link between pre-eclampsia, overweight/obesity and chronic kidney disease, the aim is to offer for obese and overweight patients to reduce their BMI without reducing lean body mass.

The POPADIPE project will make it possible to limit overweight or obesity by means of nutritional management chosen by the patient (hypocaloric or a dissociated diet). The latter has been the subject of little scientific investigation, particularly in relation to the management of post-pre-eclampsia.

Inclusion: Person affiliated to social security; Free, informed and written consent signed by the participant and the investigator (no later than the day of day of inclusion and before any examination required by the research); Patient over 18 years of age at the time of inclusion and < 45 years of age; Having had an pre-eclampsia in the last 5 years according to the definitions of the ISSHP 2018; Patient with a BMI between 25 kg/m² and 40 kg/m² who accepts dietetic follow up; Patient with a medical prescription for dietetic follow-up aimed at losing weight loss; Patient with a balanced diet.

Exclusion: Patients undergoing steroid treatment and/or immunosuppression; Patients under psychiatric care; Patients with cognitive disorders or defined eating disorders; Patients with a mental disability or language barrier that prevents them from understanding or consenting to the study; Patients deprived of their liberty by judicial or administrative decision; Patients subject to a legal protection measure; Patients who are pregnant or breast-feeding; Have been on a low-calorie or dissociated diet for at least 6 months; Patients with CKD stage ≥ 3A.

ClinicalTrials.gov NCT06067906